Zentek Ltd. (TSXV:ZEN)
0.890
+0.020 (2.30%)
At close: Mar 9, 2026
Zentek Revenue
Zentek had revenue of 65.28K CAD in the quarter ending December 31, 2025, with 73.07% growth. This brings the company's revenue in the last twelve months to 942.88K, up 1,358.30% year-over-year. In the fiscal year ending March 31, 2025, Zentek had annual revenue of 872.50K with 2,826.26% growth.
Revenue (ttm)
942.88K
Revenue Growth
+1,358.30%
P/S Ratio
101.51
Revenue / Employee
52.38K
Employees
18
Market Cap
95.71M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 872.50K | 842.68K | 2,826.26% |
| Mar 31, 2024 | 29.82K | -43.04K | -59.07% |
| Mar 31, 2023 | 72.86K | -274.33K | -79.02% |
| Mar 31, 2022 | 347.18K | 344.83K | 14,642.38% |
| Mar 31, 2021 | 2.36K | - | - |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Curaleaf Holdings | 1.74B |
| Extendicare | 1.66B |
| Sienna Senior Living | 1.00B |
| Green Thumb Industries | 1.61B |
| Grown Rogue International | 30.85M |
| Medexus Pharmaceuticals | 136.34M |
| NetraMark Holdings | 165.26K |
| BioNxt Solutions | 15.82K |
Zentek News
- 10 hours ago - Zentek Provides PDAC 2026 Update - Government and First Nations Engagement - Accesswire
- 5 days ago - Zentek Announces Pilot Evaluation Program with Quality Filters Inc. - Accesswire
- 11 days ago - Zentek Outlines Government Engagement Strategy and Announces Plans to Advance Albany Graphite Toward New Preliminary Economic Assessment - Accesswire
- 12 days ago - Zentek Ltd. Granted 180-Day Extension to Regain Compliance with Nasdaq's Minimum Bid Price Requirement - Accesswire
- 20 days ago - Zentek Provides Strategic and Regulatory Update - Accesswire
- 5 weeks ago - Zentek Issues Shareholder Letter Outlining Strategic Reset and Focused Growth Plan - Newsfile Corp
- 2 months ago - Zentek's Albany Graphite Has Demonstrated Nuclear Grade Performance in Independent Testing, Opening Pathways Into a Range of High-Return Commercial Markets - Accesswire
- 2 months ago - Zentek Subsidiary Albany Graphite Corp. Achieves Near-Theoretical Anode Performance in Battery Suitability Independent Testing - Accesswire